PubMed Health⌕ Search

Biomedical subjects

Jiacang Wang

Publications and source records attributed to Jiacang Wang.

2 recordsLinked to original sources

[116 multiple primary cancers in the digestive system].

OBJECTIVE: To study the clinical characteristics, diagnosis, strategy of treatment and prognosis of multiple primary cancers in the digestive system. METHODS: All malignant lesions in the digestive system encountered in the past 10 years were analysed by a computer software. RESULTS: 116 cases of multiple cancers were observed with an incidence of 1.74%. Male to female ratio was 2.7:1. There were 62 synchronous carcinomas and 54 metachronous ones. In decreasing sequence, they were: colon > stomach > rectum > liver. The 1-, 3-and 5-year survival rates of the synchronous ones were 42.3%, 23.1% and 11.5%. Those of metachronous ones were 95.2%, 85.7% and 76.2%. CONCLUSION: High frequency of multiple primary cancers is found in the colon, especially over the right side. Metachronous carcinomas usually give better prognosis than the synchronous ones. The longer the interval between the development of the two primary lesions, the better the prognosis. Multiple cancers of the colon have satisfactory prognosis. The key to improve the treatment is to be vigilant against lesions in the digestive tract so as to arrive at a timely diagnosis and treatment. The strategy of combining radical treatment with immuno-supportive therapy is advocated.

Colonic Neoplasms↗

Diagnosis and treatment of primary gastric non-Hodgkin's lymphoma: analysis of 157 patients.

OBJECTIVE: To seek the optimum treatment for patients with primary gastric non-Hodgkin's lymphoma and factors associated with prognosis. METHODS: A retrospective study was conducted on 157 primary gastric non-Hodgkin's lymphoma patients who had received operation for 45 years. RESULTS: The X-ray diagnosis rate was 39.4% before operation. The diagnosis rate by gastroscopy was 52.7%. Among the 157 patients, 32 belonged to stage I(E), 40 stage II(E), 29 stage III(E), and 56 stage IV(E). All of the patients were received chemotherapy or radiation. The 3-, 5-, 10-, 15-year survival rates were 51.1% (69/135), 42.3% (55/130), 20.7% (23/111), and 13.5% (14/104). CONCLUSIONS: The 3-, 5-year survival rates in stage I(E) and stage II(E) were 2 to 5 times higher than those in stage III(E) and IV(E) (P < 0.01). The 3-, 5-year survival rates of primary gastric non-Hodgkin's lymphoma were 60.2% (65/108) and 50.0% (52/104) respectively. The prognosis was better than the 5-year survival rate of gastric cancer patients with D(2) lymphodenectomy (33.3%). Early diagnosis and treatment are effective to prevent complications, enhance quality of patient's life, and prolong the survival.

Humans↗